Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

No studies about Samarium chloride were available, but studies about analogue compounds:
oral: LD50 (rat) = 2900 mg / kg bw Samarium nitrate (analogue substance)
oral: LD50 (rat) = 2621 mg/kg bw Lanthanum chloride, anhydrous (original value: 3200 mg/kg bw Lanthanum chloride trihydrate) (analogue substance)
dermal: LD50 (rabbit) > 1638 mg/kg bw Lanthanum chloride, anhydrous ((original value: > 2000 mg/kg bw Lanthanum chloride trihydrate) (analogue substance)

Key value for chemical safety assessment

Additional information

Oral

No studies about Samarium chloride were available but following studies about the analogue substances:

- Samarium nitrate

The acute oral toxicity of Samarium nitrate was tested on rats. It turned out that this substance was 7 to 11 times more toxic to females than to male rates. for female rats the LD50 was measured with 2900 mg Samarium nitrate/kg bw.

- Lanthanum chloride

The acute oral toxicity of Lanthanum chloride trihydrate was tested according to the Guideline of the Department of Transportation (D.O.T), Code of Federal Regulations, Title 49, Part 173. The test substance was administered to rats at a dose range of 2820 - 4470 mg/kg bw, mortality and clinical signs were observed for 48 h. The LD50 was 3200 mg Lanthanum chloride trihydrate/kg bw, corresponding to 2621 mg Lanthanum chloride, anhydrous/kg bw.

Inhalation

There are no data available on acute inhalation toxicity of Samarium chloride. Due to the possibly exposure routes here no study was conducted.

Dermal

No study about Samarium chloride was available, but one about the analogue substance Lanthanum chloride trihydrate:

The acute dermal toxicity of Lanthanum chloride trihydrate was tested according to the Guideline of the Department of Transportation (D.O.T), Code of Federal Regulations, Title 49, Part 173. After acute dermal application of 2000 mg/kg bw to the intact skin of rabbits for 24 h under occlusive conditions, no signs of systemic toxicity were observed after an observation time of 48 h. The intact skin showed very slight erythema and very slight edema after 24 h, no signs of erythema and edema were detected after 48 h. The LD50 can be stated as > 2000 mg Lanthanum chloride trihydrate, corresponding to > 1638 mg Lanthanum chloride, anhydrous/kg bw.

Other routes

Localisation and biological effects of an intratracheal instillation of up to and including 50 µg Lanthanum chloride/rat was investigated (Suzuki et al., 1992). Sacrifice of exposed animals at various time points (3 hours to 168 days) after treatment revealed that Lanthanum accumulated in a dose-related manner in the lung in an insoluble form resulting in a biological half-life of approximately 244 days. In addition, administered Lanthanum chloride could not only be detected in various cell types in the lung but also in pulmonary lymph nodes.

Justification for classification or non-classification

There are conclusive data available, but they are not sufficient for classification.